The global influenza medication market size stood at USD 889.2 million in 2018 and is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period
It's been an unusual 2022 influenza season in the southern hemisphere. Early weekly surges in laboratory-confirmed cases and influenza-like illness are exceeding the 5-year average, according to the Australian Government Department of Health and Aged Care
The questions on the minds of the US experts are, what can we expect on this side of the globe? and how can public health professionals and clinicians prepare for what portends to be an especially severe season?
State Health, Environment, Cooperatives and Consumerism Action Committee chairman S. Veerapan said the Seremban district recorded the highest number of cases at 4,923, Tampin (3,877), Jempol (2,255), Jelebu (2,050), Kuala Pilah (973), Port Dickson (824) and Rembau (323).
Get a Sample Copy of the Report at – https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/101843
"We're seeing there is really a massive increase in cases, and perhaps even more interesting is the fact that these cases are coming at a much earlier time than is normally expected in Australia," Andy Pekosz, PhD, a virologist at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland, told Medscape Medical News.
“There have been nine cumulative outbreaks of ILI recorded in the state this year and there are no active ILI outbreaks. There have been no closures of schools or kindergartens due to the outbreak, and no reported deaths,” he said in a statement here today.
Meanwhile, he advised those at risk, especially senior citizens and children, to seek early treatment if they display symptoms such as fever, flu, cough and diarrhoea.
He also advised the public to regularly wash their hands and avoid visiting crowded places apart from practicing proper coughing etiquette. ― Bernama
Key players covered in the global Influenza Medication Market research report:
- Genentech, Inc.
- Shionogi & Co., Ltd.
- Seqirus (CSL)
- BIOCRYST PHARMACEUTICALS, INC.
- GlaxoSmithKline plc
- Lupin Limited
- Teva Pharmaceutical Industries Ltd.
- Zydus Pharmaceuticals, Inc. (Zydus Cadila)
- Amneal Pharmaceuticals LLC
- Macleods Pharmaceuticals Ltd.
- Alvogen
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Comments
Post a Comment